Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners

RLF-100™ (Aviptadil) is in advanced stages of phase 2b/3 development in the US Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) has been reported under FDA Emergency Use IND authorization at multiple clinical site... Biopharmaceuticals Relief Therapeutics, NeuroRx , Aviptadil, COVID-19
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news